• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合β3/β2 - 肾上腺素能受体揭示的受体亚型特异性调节的结构基础

Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

作者信息

Liggett S B, Freedman N J, Schwinn D A, Lefkowitz R J

机构信息

Department of Medicine (Pulmonary), University of Cincinnati Medical Center, OH 45267.

出版信息

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3665-9. doi: 10.1073/pnas.90.8.3665.

DOI:10.1073/pnas.90.8.3665
PMID:8386380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC46362/
Abstract

The physiological significance of multiple G-protein-coupled receptor subtypes, such as the beta-adrenergic receptors (beta ARs), remains obscure, since in many cases several subtypes activate the same effector and utilize the same physiological agonists. We inspected the deduced amino acid sequences of the beta AR subtypes for variations in the determinants for agonist regulation as a potential basis for subtype differentiation. Whereas the beta 2AR has a C terminus containing 11 serine and threonine residues representing potential sites for beta AR kinase phosphorylation, which mediates rapid agonist-promoted desensitization, only 3 serines are present in the comparable region of the beta 3AR, and they are in a nonfavorable context. The beta 3AR also lacks sequence homology in regions which are important for agonist-mediated sequestration and down-regulation of the beta 2AR, although such determinants are less well defined. We therefore tested the idea that the agonist-induced regulatory properties of the two receptors might differ by expressing both subtypes in CHW cells and exposing them to the agonist isoproterenol. The beta 3AR did not display short-term agonist-promoted functional desensitization or sequestration, or long-term down-regulation. To assign a structural basis for these subtype-specific differences in agonist regulation, we constructed a chimeric beta 3/beta 2AR which comprised the beta 3AR up to proline-365 of the cytoplasmic tail and the C terminus of the beta 2AR. When cells expressing this chimeric beta 3/beta 2AR were exposed to isoproterenol, functional desensitization was observed. Whole-cell phosphorylation studies showed that the beta 2AR displayed agonist-dependent phosphorylation, but no such phosphorylation could be demonstrated with the beta 3AR, even when beta AR kinase was overexpressed. In contrast, the chimeric beta 3/beta 2AR did display agonist-dependent phosphorylation, consistent with its functional desensitization. In addition to conferring functional desensitization and phosphorylation to the beta 3AR, the C-terminal tail of the beta 2AR also conferred agonist-promoted sequestration and long-term receptor down-regulation.

摘要

多种G蛋白偶联受体亚型,如β-肾上腺素能受体(βARs),其生理意义仍不清楚,因为在许多情况下,几种亚型激活相同的效应器并利用相同的生理激动剂。我们检查了βAR亚型推导的氨基酸序列中激动剂调节决定因素的变化,作为亚型分化的潜在基础。β2AR的C末端含有11个丝氨酸和苏氨酸残基,代表βAR激酶磷酸化的潜在位点,该磷酸化介导快速的激动剂促进的脱敏作用,而β3AR的可比区域仅存在3个丝氨酸,且它们处于不利的环境中。β3AR在对激动剂介导的β2AR隔离和下调很重要的区域也缺乏序列同源性,尽管这些决定因素的定义不太明确。因此,我们通过在CHW细胞中表达两种亚型并将它们暴露于激动剂异丙肾上腺素,来测试这两种受体的激动剂诱导调节特性可能不同的想法。β3AR没有表现出短期激动剂促进的功能脱敏或隔离,也没有长期下调。为了为激动剂调节中这些亚型特异性差异确定结构基础,我们构建了一种嵌合β3/β2AR,它由直到细胞质尾巴脯氨酸-365的β3AR和β2AR的C末端组成。当表达这种嵌合β3/β2AR的细胞暴露于异丙肾上腺素时,观察到功能脱敏。全细胞磷酸化研究表明,β2AR表现出激动剂依赖性磷酸化,但即使βAR激酶过表达,β3AR也未显示出这种磷酸化。相反,嵌合β3/β2AR确实表现出激动剂依赖性磷酸化,与其功能脱敏一致。除了赋予β3AR功能脱敏和磷酸化外,β2AR的C末端尾巴还赋予激动剂促进的隔离和长期受体下调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c37/46362/2ec6d7a03b21/pnas01467-0559-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c37/46362/2ec6d7a03b21/pnas01467-0559-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c37/46362/2ec6d7a03b21/pnas01467-0559-a.jpg

相似文献

1
Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.嵌合β3/β2 - 肾上腺素能受体揭示的受体亚型特异性调节的结构基础
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3665-9. doi: 10.1073/pnas.90.8.3665.
2
The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.人类β3-肾上腺素能受体对短期激动剂促进的脱敏具有抗性。
Mol Pharmacol. 1993 Apr;43(4):548-55.
3
Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.中国仓鼠成纤维细胞中β1-和β2-肾上腺素能受体的不同调节
Mol Pharmacol. 1992 Mar;41(3):542-8.
4
Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.β1和β2肾上腺素能受体表现出与Gs的亚型选择性偶联。
Mol Pharmacol. 1992 May;41(5):889-93.
5
Role of beta ARK in long-term agonist-promoted desensitisation of the beta 2-adrenergic receptor.β-ARK在β2-肾上腺素能受体长期激动剂促进脱敏中的作用。
Cell Signal. 1998 Mar;10(3):197-204. doi: 10.1016/s0898-6568(97)00112-5.
6
A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation.β-肾上腺素能受体的一个小区域选择性地参与其快速调节。
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):2979-83. doi: 10.1073/pnas.88.8.2979.
7
Differences in desensitization between human beta 1- and beta 2-adrenergic receptors stably expressed in transfected hamster cells.转染仓鼠细胞中稳定表达的人β1 -和β2 -肾上腺素能受体脱敏作用的差异。
Cell Signal. 1995 Mar;7(3):207-17. doi: 10.1016/0898-6568(94)00091-o.
8
Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.人β2-肾上腺素能受体羧基末端酪氨酸残基参与激动剂诱导的受体下调。
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5089-93. doi: 10.1073/pnas.87.13.5089.
9
Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines.β2-肾上腺素能受体/Gsα融合蛋白的激活引发一种能够抑制两种癌细胞系增殖的脱敏抗性cAMP信号。
Recept Channels. 1997;5(1):41-51.
10
Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2.α2 - 肾上腺素能受体的亚型选择性脱敏。不同机制控制α2C10、α2C4和α2C2的短期和长期激动剂促进的脱敏。
J Biol Chem. 1992 Dec 15;267(35):25473-9.

引用本文的文献

1
Recent Developments in the Optical Control of Adrenergic Signaling.肾上腺素能信号传导光学控制的最新进展
Med Res Rev. 2025 Sep;45(5):1307-1322. doi: 10.1002/med.22110. Epub 2025 Apr 3.
2
The β-Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential.β-肾上腺素能受体:结构、疾病的病理生理学及新兴治疗潜力
Adv Pharmacol Pharm Sci. 2024 Nov 28;2024:2005589. doi: 10.1155/2024/2005589. eCollection 2024.
3
The role of compartmentalized β-AR/cAMP signaling in the regulation of lipolysis in white and brown adipocytes.

本文引用的文献

1
Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.β-肾上腺素能受体隔离:受体再敏化的一种潜在机制。
J Biol Chem. 1993 Jan 5;268(1):337-41.
2
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.短肽产生蛋白质反应性抗体是一个高频事件:对免疫识别结构基础的启示。
Proc Natl Acad Sci U S A. 1983 Aug;80(16):4949-53. doi: 10.1073/pnas.80.16.4949.
3
Use of eukaryotic expression technology in the functional analysis of cloned genes.
区室化β-肾上腺素能受体/cAMP信号在白色和棕色脂肪细胞脂解调节中的作用。
FEBS J. 2025 Jan;292(2):261-271. doi: 10.1111/febs.17157. Epub 2024 May 15.
4
The β3-AR agonist BRL37344 ameliorates the main symptoms of X-linked nephrogenic diabetes insipidus in the mouse model of the disease.β3肾上腺素能受体激动剂BRL37344可改善X连锁肾性尿崩症小鼠模型的主要症状。
J Cell Mol Med. 2024 Apr;28(8):e18301. doi: 10.1111/jcmm.18301.
5
Therapeutic Potential for Beta-3 Adrenoreceptor Agonists in Peripheral Arterial Disease and Diabetic Foot Ulcers.β-3肾上腺素能受体激动剂在周围动脉疾病和糖尿病足溃疡中的治疗潜力
Biomedicines. 2023 Nov 30;11(12):3187. doi: 10.3390/biomedicines11123187.
6
Proximity Interactome Analysis of Super Conserved Receptors Expressed in the Brain Identifies EPB41L2, SLC3A2, and LRBA as Main Partners.大脑中表达的超级保守受体的邻近互作组分析确定 EPB41L2、SLC3A2 和 LRBA 为主要伴侣。
Cells. 2023 Nov 14;12(22):2625. doi: 10.3390/cells12222625.
7
Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension.在高血压人源化血管紧张素原模型中,钙调蛋白激酶II(CaMKII)激活增加以及心脏β1和β3肾上腺素能信号通路的对比变化。
Heliyon. 2023 Jun 30;9(7):e17851. doi: 10.1016/j.heliyon.2023.e17851. eCollection 2023 Jul.
8
Measuring the Rate of Lipolysis in Ex vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro.测量离体鼠脂肪组织和体外分化的原代前体脂肪细胞的脂解率。
J Vis Exp. 2023 Mar 17(193). doi: 10.3791/65106.
9
Lubabegron fumarate acts as a β-adrenergic receptor antagonist in cultured bovine intramuscular and subcutaneous adipocytes.富马酸芦巴碱在培养的牛肌内和皮下脂肪细胞中作为β-肾上腺素能受体拮抗剂起作用。
J Anim Sci. 2022 Mar 1;100(3). doi: 10.1093/jas/skac052.
10
β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity.β3-肾上腺素能受体下调导致肥胖症中脂肪细胞儿茶酚胺抵抗。
J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI153357.
真核表达技术在克隆基因功能分析中的应用。
Methods Enzymol. 1987;152:684-704. doi: 10.1016/0076-6879(87)52074-2.
4
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.人β2-肾上腺素能受体的互补DNA:一种具有多个跨膜结构域的蛋白质,由一个基因编码,该基因的染色体定位与血小板衍生生长因子受体的染色体定位相同。
Proc Natl Acad Sci U S A. 1987 Jan;84(1):46-50. doi: 10.1073/pnas.84.1.46.
5
Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.用嵌合β1/β2 - 肾上腺素能受体研究β - 肾上腺素能受体亚型特异性的结构基础。
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9494-8. doi: 10.1073/pnas.85.24.9494.
6
Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.嵌合α2-、β2-肾上腺素能受体:参与效应器偶联和配体结合特异性的结构域的描绘
Science. 1988 Jun 3;240(4857):1310-6. doi: 10.1126/science.2836950.
7
Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization.从β2 - 肾上腺素能受体上去除磷酸化位点会延迟激动剂促进的脱敏作用的起始。
Nature. 1988 May 26;333(6171):370-3. doi: 10.1038/333370a0.
8
Cloning of the cDNA for the human beta 1-adrenergic receptor.人β1 - 肾上腺素能受体cDNA的克隆
Proc Natl Acad Sci U S A. 1987 Nov;84(22):7920-4. doi: 10.1073/pnas.84.22.7920.
9
Molecular characterization of the human beta 3-adrenergic receptor.人β3 -肾上腺素能受体的分子特征
Science. 1989 Sep 8;245(4922):1118-21. doi: 10.1126/science.2570461.
10
Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites.在表达缺乏磷酸化位点的突变型β2-肾上腺素能受体的细胞中,激动剂刺激的环磷酸腺苷(cAMP)积累模式发生改变。
Mol Pharmacol. 1989 Oct;36(4):641-6.